Projects and Awards

Get to know our projects and awards

Projects

Qubiotech is a company active in the identification, preparation and management of R + D + i projects. Our interests in this activity lie in neurodegeneration and ICT solutions with artificial intelligence to support diagnosis.

If you have a project idea and are looking for a partner, do not hesitate to contact us!

Request more information

 

The Ministry of Science and Innovation grants funding to Qubiotech for the development of the “Early molecular nanoDIAGnostics of Brain tumors using Immune-PET (DIAGBI)-(PLEC2021-008034)” project with the aim of facilitating the early and non-invasive diagnosis of brain tumours

The aim of the project is to develop a new technology that allows early diagnosis and non-invasive monitoring of the most aggressive brain tumours with the lowest life expectancy for patients, such as glioblastomas. Currently, diagnosis requires biopsies of tumour tissue by neurosurgery, an operation that requires a great deal of planning and is traumatic for patients. In other types of tumours, however, it has been possible to apply immuno-PET techniques for tumour characterisation using antibodies linked to Positron Emission Tomography (PET) radiotracers, which allow the tumour to be diagnosed without the need to remove the tissue. However, in brain tumours, the blood-brain barrier, a film that protects the brain from the entry of foreign substances into the body, has prevented the application of these non-invasive techniques. The DIAGBI project aims to overcome this barrier by using nanoparticles, capable of penetrating it, to carry PET tracers along with the antibodies needed for genetic characterisation of the tumour. In this way, it would be possible to speed up diagnosis and follow-up times and avoid difficult and costly neurosurgical interventions. The ultimate goal is to improve and extend the quality of life of patients and to make more efficient use of health care resources.

Logo Ministerio de Ciencia e Innovacion

Project call Challenges Collaboration 2019

Qubiotech Health Intelligence participates in the project “MOBILE HEALTH SOLUTION BASED ON GENETIC PROFILE, IMAGE ANALYSIS AND CONTINUOUS MONITORING OF SYMPTOMS FOR THE PERSONALIZED MANAGEMENT OF PATIENTS WITH PARKINSON’S DISEASE (GiMO-PD) funded by the Ministry RTC2019-7150-1” of Science and Innovation.

The project, which will take place between 2020 and 2023, will be developed by a consortium of 3 companies and two public research organizations and aims to develop a solution that can be integrated into the healthcare circuit that facilitates the diagnosis and monitoring of patients with Parkinson. In this project, Qubiotech is responsible for the development of a SPECT image analysis software that identifies biomarkers of image characteristic of the disease for its later integration with other clinical data and to develop evaluation models and disease progression.

EIT Health Product/Market Fit

Qubiotech has been one of the 15 European start-ups participating in the accelerator of the European Institute of Technology – Health Product / Market Fit. This project will allow us to access the British market more quickly.

Neotec

Qubiotech has been one of the three Galician companies benefiting from the NEOTEC Grants (CDTI) in the 2016 call. This aid of € 200,000 will allow the development of new products and their commercialization in Spain and Europe.

Aids Re-Acciona (IGAPE)

Qubiotech has been selected for the granting of the IGAPE Re-Acciona aid to improve competitiveness.

Awards and honours

 

 
February 4, 2014

Award Galician Biotechnology Cluster

Award to the Best Business idea for setting up a biotech company

 
February 4, 2014
 
March 12, 2015

Award University of Santiago de Compostela

Best Young Company

 
March 12, 2015
 
May 3, 2015

Bayer Grants4Apps-Barcelona

Selected by Bayer to join Grants4Apps coworking Barcelona

 
May 3, 2015
 
July 8, 2015

Financial Circle-AJE Santiago de Compostela

Award “Innova-Emprende” to the best Innovative idea for setting up new companies

 
July 8, 2015
 
September 12, 2015

Royal Galician Academy of Sciences

Award for the Best Technology Transfer case

 
September 12, 2015
 
January 19, 2016

StartupXplore

Selected among 10 leading start ups in Health sector in Spain

 
January 19, 2016
 
February 24, 2016

Pioneers Festival

Selected for joining Pioners 500 pitchs

 
February 24, 2016
 
April 28, 2016

Health 2.0 Europe

Selected for pitching the Project at EC2VC and selected for demoing live

 
April 28, 2016
 
June 18, 2016

German Chamber of Commerce Phiosphere Awards

Selected among 10 top companies (out of 65 aplications) for pitching at the final award

 
June 18, 2016
 
August 4, 2016

VI Edición Premio Ideas

A Modern Galicia Foundation

 
August 4, 2016
 
September 16, 2016

Everis Foundation

Selected for latest round

 
September 16, 2016
 
October 6, 2016

Hoffman-LaRoche

One of 5 spin offs selected for attending to Roche Partnering for Innovation Summit

 
October 6, 2016
 
November 17, 2016

Telefonica-Galicia Open Future

One of the 3 winners

 
November 17, 2016
 
December 8, 2016

I eHealth Roadshow @ World of Health IT Conference

One of 12 selected companies for pitching their projects

 
December 8, 2016
 
April 22, 2017

Neotec Grant (CDTI)

Awarded with 200k€ grant for Business Plan development for 2017 and 2018

 
April 22, 2017
 
June 14, 2017

EIT Health Product/Market Fit

Selected for EIT Health Product/Market Fit program for UK market exploration

 
June 14, 2017
 
October 29, 2017

Agrobiotech

Selected for Agrobiotech acceleration program

 
October 29, 2017
 
July 18, 2018

Premios EmprendedorXXI

Galician winner of the EmprendedorXXI awards

 
July 18, 2018
 
September 28, 2018

H2020

SME Phase 1

 
September 28, 2018
 
Sello Galicia Avanza